Day: May 30, 2026

MMJ ET AL PREPARES APPEAL CMS HEMP PROGRAM: How Can a Company With a Manufactured Pharmaceutical Soft Gel Be Told It Has “No Product”?

JUDGE McFADDEN SAID MMJ HAS "NO PRODUCT." THE RECORD SAYS OTHERWISE.How Can a Company With FDA INDs, Orphan Drug Designation,...

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development...

Bioma Probiotics Claims Evaluated: What the 2026 Gut Health Research Reveals About This Seed Probiotics Alternative, Its Ingredients, Weight Loss Support, and Consumer Reviews

An independent, research-informed evaluation of the Bioma probiotic formulation — examining its ingredients, dosage disclosure, weight-loss positioning, consumer reviews, and...

error: Content is protected !!